𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Drug resistance in human lung cancer cell lines: Cross-resistance studies and effects of the calcium transport blocker, verapamil

✍ Scribed by Peter R. Twentyman; Norma E. Fox; Norman M. Bleehen

Publisher
Elsevier Science
Year
1986
Tongue
English
Weight
437 KB
Volume
12
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A study of cross-resistance pattern and
A study of cross-resistance pattern and expression of molecular markers of multidrug resistance in a human small-cell lung-cancer cell line selected with doxorubicin
✍ Rosanna Supino; Monica Binaschi; Giovanni Capranico; Romolo A. Gambetta; Elena S 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 920 KB

## Abstract A doxorubicin‐resistant variant of the human small‐cell lung‐cancer cell line N592 was selected by __in vitro__ continuous exposure to increasing drug concentrations. The aim of this study was to examine the cross‐resistance pattern, cellular pharmacokinetics of doxorubicin and expressi

Differential effects of verapamil and qu
Differential effects of verapamil and quinine on the reversal of doxorubicin resistance in a human leukemia cell line
✍ Sanae Bennis; François Ichas; Jacques Robert 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 901 KB

## Abstract We studied the restoration of doxorubicin accumulation and sensitivity by verapamil and quinine in a variant of the human erythroleukemia cell line K562 selected for resistance to doxorubicin and presenting a multidrug‐resistance (MDR) phenotype. Verapamil was able to completely restore

Antiproliferative effects of the histone
Antiproliferative effects of the histone deacetylase inhibitor FR901228 on small-cell lung cancer lines and drug-resistant sublines
✍ Junji Tsurutani; Hiroshi Soda; Mikio Oka; Mitsuhiro Suenaga; Seiji Doi; Yoichi N 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 248 KB 👁 1 views

## Abstract FR901228 is a novel histone deacetylase (HDAC) inhibitor, and its antiproliferative effects on non‐small cell lung cancer cells have been shown __in vitro__. However, there have been no reports concerning the effects on small‐cell lung cancer (SCLC). We have recently demonstrated that t

Upregulation of bcl-2 is involved in the
Upregulation of bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines
✍ Ute A. Sartorius; Peter H. Krammer 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 325 KB

## Abstract Chemotherapeutic drugs eliminate cancer cells by induction of apoptosis. Resistance to chemotherapy is partly due to a decreased apoptosis rate. Here we investigated resistance to anticancer drugs in 9 small cell lung cancer (SCLC) cell lines. Apoptosis was induced by cisplatin, doxorub

The effect of hypoxia on acquired drug r
The effect of hypoxia on acquired drug resistance and response to epidermal growth factor in chinese hamster lung fibroblasts and human breast-cancer cells in vitro
✍ R. Kalra; A-M. Jones; J. Kirk; G. E. Adams; I. J. Stratford 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 646 KB

## Abstract Prolonged hypoxia induced transient drug resistance in Chinese hamster lung fibroblasts. Previously hypoxic cells were resistant to adriamycin and resistant to etoposide. Complete recovery of etoposide sensitivity was observed following re‐aeration for 24 hr. A change in P‐glycoprotein

Doxorubicin induces expression of multid
Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway
✍ Chie Shinoda; Muneharu Maruyama; Takashi Fujishita; Junichi Dohkan; Hirofumi Oda 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 646 KB

Multidrug resistance (MDR) is a major impediment to successful chemotherapy for lung cancer. Overexpression of multidrug resistance-associated protein 1 (MRP1) appears to be involved in MDR development in lung cancer cells. A number of chemotherapeutic agents including doxorubicin (DOX) were reporte